60 Degrees Pharmaceuticals (SXTP) Short term Debt (2022 - 2025)
60 Degrees Pharmaceuticals (SXTP) posted quarterly Short term Debt of $8772.0 for Q4 2025, little changed year-over-year from $8772.0 in Q4 2024, and little changed quarter-over-quarter from $8772.0 in Q4 2024.
60 Degrees Pharmaceuticals (SXTP) Short term Debt (2022 - 2025) Analysis & Trends
60 Degrees Pharmaceuticals (SXTP) has reported Short term Debt for 4 consecutive years, with $8772.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Short term Debt changed 0.0% year-over-year to $8772.0; the TTM figure through Dec 2025 stood at $8772.0 (changed 0.0% YoY), while the FY2025 annual figure was $8772.0, changed 0.0% from the prior year.
- Short term Debt held at $8772.0 in Q4 2025 per SXTP's latest filing, from $8772.0 in the prior quarter.
- Across five years, Short term Debt topped out at $23.5 million in Q2 2023 and bottomed at $8772.0 in Q1 2024.
- Historically, Short term Debt has averaged $4.6 million across 4 years, with a median of $11211.0 in 2023.
- Annual changes were most pronounced in 2023 — Short term Debt sank 99.68% — and 2025, when it changed 0.0%.
- 60 Degrees Pharmaceuticals' Short term Debt stood at $4.3 million in 2022, then tumbled by 99.68% to $13650.0 in 2023, then slumped by 35.74% to $8772.0 in 2024, then changed by 0.0% to $8772.0 in 2025.
- Business Quant data shows SXTP's Short term Debt at $8772.0 in Q4 2025, $8772.0 in Q4 2024, and $8772.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.93 Bn | 131.07 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.91 Bn | 77.92 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.98 Bn | 59.80 Bn | 1.37 Bn |
| 4 | Moderna | 58.86 Bn | 53.72 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.54 Bn | 28.23 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.88 Bn | 9.49 Bn | 668.28 Mn |
| 8 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.35 Bn | 26.51 Bn | - |
| 10 | 60 Degrees Pharmaceuticals | 3.00 Mn | 1.98 Mn | 56,798.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 8,772.00 |
| Dec 31, 2024 | 8,772.00 |
| Mar 31, 2024 | 8,772.00 |
| Dec 31, 2023 | 13,650.00 |
| Jun 30, 2023 | 23.54 Mn |
| Dec 31, 2022 | 4.28 Mn |